Cresset Asset Management, LLC Harmony Biosciences Holdings, Inc. Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 71,765 shares of HRMY stock, worth $2.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71,765
Previous 64,208
11.77%
Holding current value
$2.81 Million
Previous $2.57 Million
3.74%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$259 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$228 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$185 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$89.1 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$61.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...